A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
Stopped early · Phase 1/Phase 2
Conditions studied: Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma, Endometrial Cancer, Ovary Cancer, Ovary Neoplasm, Ovary Disease, Ovary Metastasis, Ovarian Diseases, Ovarian Cancer Stage, Ovarian Epithelial Cancer, Ovarian Adenocarcinoma, Ovarian Serous Adenocarcinoma, Ovarian Neoplasm Epithelial, Ovarian Cancer Recurrent, Endometrial Diseases, Endometrial Adenocarcinoma, Endometrial Carcinosarcoma, Endometrial Clear Cell Adenocarcinoma, Endometrioid Adenocarcinoma, Endometrial Neoplasms, Endometrial Cancer Recurrent, Endometrioid Tumor, Fallopian Tube Cancer, Peritoneal Cancer
In brief
This study, ELU- FRα-1, was focused on adult subjects who have advanced, recurrent or refractory folate receptor alpha (FRα) overexpressing tumors considered to be topoisomerase 1 inhibitor-sensitive based on scientific literature, and, in the opinion of the Investigator, have no other meaningful life-prolonging therapy options available.
Key facts
- Study ID
- NCT05001282
- Run by
- Elucida Oncology
- People needed
- 79
- Starts
- 2021-09-13
- Expected to finish
- 2024-06-07
- Last updated by the study team
- 2024-08-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic - Phoenix, AZ — Phoenix, Arizona, United States
- Providence Medical Foundation — Fullerton, California, United States
- Mayo Clinic - Jacksonville, FL — Jacksonville, Florida, United States
- D&H Cancer Research Center — Margate, Florida, United States
- Sarah Cannon Research Institute at Florida Cancer Specialists — Orlando, Florida, United States
- Hope and Healing Cancer Services — Hinsdale, Illinois, United States
- OSF Saint Francis Medical Center — Peoria, Illinois, United States
- Mayo Clinic - Rochester, MN — Rochester, Minnesota, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- Duke University Medical Center - Duke Cancer Institute — Durham, North Carolina, United States
- Cleveland Clinic — Cleveland, Ohio, United States
- Thomas Jefferson University, Sidney Kimmel Cancer Center — Philadelphia, Pennsylvania, United States
- Women & Infants Hospital of Rhode Island — Providence, Rhode Island, United States
- Avera Cancer Institute — Sioux Falls, South Dakota, United States
- Sarah Cannon Research Institute at Tennessee Oncology — Nashville, Tennessee, United States
- Mary Crowley Cancer Research — Dallas, Texas, United States
- New Experimental Therapeutics of San Antonio (NEXT Oncology) — San Antonio, Texas, United States
- Fred Hutchinson Cancer Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.